Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/27/2025 | $8.50 | Neutral → Buy | UBS |
| 4/8/2025 | $9.00 | Overweight | KeyBanc Capital Markets |
| 4/3/2025 | $8.00 | Buy | Canaccord Genuity |
| 12/16/2024 | $10.00 | Neutral → Buy | Goldman |
| 1/3/2024 | $7.00 | Underweight | Barclays |
| 5/15/2023 | $8.00 → $9.00 | Outperform → Market Perform | TD Cowen |
| 1/6/2023 | $8.00 | Equal-Weight → Overweight | Morgan Stanley |
| 11/7/2022 | $7.25 | Buy | Jefferies |
SCOTTSDALE, Ariz., May 28, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ:LFST), one of the nation's largest providers of outpatient mental health care, today announced that management will present at the upcoming 46th Annual Goldman Sachs Healthcare Conference, which will be hosted in Miami, Florida. Details of the presentation are as follows:Presenters: Dave Bourdon, CEO, and Ryan McGroarty, CFODate: Tuesday, June 10, 2025 Time: 10:40 a.m. (Eastern time)Moderated by: Jamie Perse The presentation will be webcast live and will be available on the Events and Presentations section of the LifeStance Health Investor Relations website (https://investor.lifestance.com).
SCOTTSDALE, Ariz., May 14, 2025 /PRNewswire/ -- LifeStance Health, one of the nation's largest providers of virtual and in-person outpatient mental health care, today announced that Vaughn Paunovich will join the company as Chief Technology Officer, effective Monday, June 9, 2025. Paunovich will lead LifeStance's end-to-end technology strategy, ensuring that the organization continues to deliver a best-in-class technology experience for its patients and clinicians. "Vaughn brings a demonstrated track record of leading high-performing technology teams and delivering digital exp
Board further strengthened with appointment of Mike McFarland as Director National Veterinary Associates Group ("NVA"), a leading veterinary care organization, today announced it has strengthened its Board with the appointments of Ken Burdick as Executive Chairman and Dr. James "Mike" McFarland as Director. These executives bring substantial healthcare and public company experience ahead of the company's future IPO. Burdick is a seasoned public company executive with more than 40 years of healthcare experience. He currently serves as Executive Chairman at LifeStance Health (NASDAQ:LFST), a leading U.S. provider of outpatient mental healthcare. Since joining LifeStance as Chairman and CEO
8-K - LifeStance Health Group, Inc. (0001845257) (Filer)
8-K - LifeStance Health Group, Inc. (0001845257) (Filer)
10-Q - LifeStance Health Group, Inc. (0001845257) (Filer)
UBS upgraded LifeStance Health Group from Neutral to Buy and set a new price target of $8.50
KeyBanc Capital Markets initiated coverage of LifeStance Health Group with a rating of Overweight and set a new price target of $9.00
Canaccord Genuity initiated coverage of LifeStance Health Group with a rating of Buy and set a new price target of $8.00
4 - LifeStance Health Group, Inc. (0001845257) (Issuer)
4 - LifeStance Health Group, Inc. (0001845257) (Issuer)
4 - LifeStance Health Group, Inc. (0001845257) (Issuer)